1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Adagio Therapeutics Inc (ADGI)
  7. Financials

ADGI

Adagio Therapeutics Inc
4.64
0.00 (0.00%)
Upgrade to Real-Time

Adagio Therapeutics Inc. (ADGI) Fundamentals
Adagio Therapeutics Inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of antibody-based solutions for infectious diseases with pandemic potential. The company's lead product candidate, ADG20 is developed for the treatment and prevention of coronavirus disease 2019, or COVID-19, the disease caused by the virus SARS-CoV-2 and its variants.
SHARE INFORMATION
Market CapUS$ 500,620,415
Shares Outstanding108,830,525
Float17,376,536
Percent Float15.97%
Short Interest0.00
Short Percent Float0.0%
Short Interest Ratio0.00
Short Interest Date-
Latest Fiscal Dividend Per ShareUS$ 0.00
Latest Fiscal RevenueUS$ 0
Latest Fiscal EPSUS$ -0.27
Latest Fiscal Date2021-12-31
DIVIDENDS
Dividend (3 Years)US$ 0.00
Dividend (5 Years)US$ 0.00
Ex Dividend Date-
Dividend RateUS$ 0.00
Dividend Yield0.0%
Payment Cash-
HOLDERS
Institutions203
Institutional Holdings Date2022-08-31
Institutional Bought Previous 3 Months3,074,510
Institutional Holdings Percent72.4%
Institutional Sold Previous 3 Months7,693,764
Insider Holdings Date2022-08-31
Insider Bought Previous 3 Months5,644,178
Insider Holdings Percent2.0
Insider Sold Previous 3 Months-
Insider Shares Owned2,122,555
TRADING INFO
52 Week HighUS$ 78.82
52 Week LowUS$ 2.41
52 Week High ChangeUS$ -90.19
21 Day Moving AverageUS$ 4.4038
21 Day Extended Moving AverageUS$ 4.4243
50 Day Moving AverageUS$ 4.0978
50 Day Extended Moving AverageUS$ 4.1396
200 Day Moving AverageUS$ 6.9912
200 Day Extended Moving AverageUS$ 8.8582
10 Day Average Volume387,915
20 Day Average Volume740,720
30 Day Average Volume637,932
50 Day Average Volume588,731
Alpha-0.064208
Beta-1.8809
Standard Deviation0.377440
R20.085410
7 Day Price ChangeUS$ -0.18
7 Day Percent Change-3.77%
21 Day Price ChangeUS$ 0.40
21 Day Percent Change9.52%
30 Day Price ChangeUS$ 0.79
30 Day Percent Change20.73%
Month to Date Price ChangeUS$ 0.04
Month to Date Percent Change0.88%
Quarter to Date Price ChangeUS$ 1.32
Quarter to Date Percent Change40.24%
180 Day Price ChangeUS$ -0.62
180 Day Percent Change-11.88%
200 Day Price ChangeUS$ -1.82
200 Day Percent Change-28.35%
Year to Date Price ChangeUS$ -2.66
Year to Date Percent Change-36.64%

Adagio Therapeutics Inc. (ADGI) Key Ratios

PROFITABILITY
EBIT Margin0.0%
EBITDA Margin0.0%
Pre-Tax Profit Margin0.0%
Profit Margin Count0.0%
Gross Margin0.0%
Profit Margin TOT0.0%
INCOME STATEMENTS
RevenueUS$ 0
Revenue Per ShareUS$ 0.00
Revenue (3 Years)US$ 0.00
Revenue (5 Years)US$ 0.00
FINANCIAL STRENGTH
Price to Tangible Book1.20
Total Debt To Equity0.00
Int Coverage0.00
Current Ratio7.10
Leverage Ratio1.10
Quick Ratio7.00
Long Term Debt To Capital0.00
VALUATION MEASURES
PE Ratio-7.20
Enterprise ValueUS$ 28,593,415
Price to Sales0.00
Price to Free Cash-2.10
PE High Last 5 Years0.00
Price To Book1.20
Price To Cash Flow0.00
PE Low Last 5 Years0.00
Price to Tangible Book1.20
MANAGEMENT EFFECTIVENESS
Receivables Turnover0.00
Invoice Turnover0.00
Assets Turnover0.00
Return Assets-66.86
Return on Equity-218.40
Return on Capital-213.87

Adagio Therapeutics Inc. (ADGI) Profile

PROFILE INFO
Issue TypeCS
SEC Type-
AuditorPricewaterhouseCoopers LLP
CEODavid Hering
Emplyoees103
Last AuditUQ
CIK0001832038
IndustryBiotechnology
SectorHealthcare
NAICSPharmaceutical Preparation Manufacturing(325412)
CONTACT INFO
Address1601 Trapelo Road
Suite 178
Waltham, MA 2451
Websitehttps://www.adagiotx.com
Facsimile-
Telephone+1 781 819-0080
Email-
Your Recent History
NASDAQ
ADGI
Adagio The..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to ADVFN
Register Now
NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V:au D:20230321 01:13:23